The present study extends the therapeutic window to include acute pyelonephritis, in this case in Irf3−/− mice, which are susceptible to infection due to a transcription factor deficiency that impairs the type I IFN response and the antibacterial defense. The gene discussed is IRF3; the disease is infection.